ANTIMICROBIAL WALL CLADDING Vs CORONAVIRUS:
How BioMax Protects Against The Virus That Causes Covid-19
We are pleased to announce that after extensive testing we can confirm that Biomaster, the component against viruses’ in our BIOMAX range is active on both porous and non-porous substrates against SARS-CoV-2.
SARS -CoV-2 is the virus that causes Covid-19 and is a member of the Coronavirus family of viruses.
Until very recently, only Government laboratories were licensed to handle the SARS -CoV-2 virus, due to the danger of the strain.
BIOMAX has now been selected by Class 3 laboratories around the world, which are able to test product s to the viral ISO standard.
150 21702 is the test for non –porous surfaces 150 18184 is the test for porous surfaces.
Porous substrate with Biomaster showed a 68% reduction of SARS-CoV-2 in 15 minutes and >99% in 4 hours.* Non-porous substrate with Biomaster showed a 60% reduction of SARS-CoV-2 in 2 hours and >99% in 24 hours.*
Results are based on comparison to controls with no Biomaster
The SaniClad team is very excited to be sharing these game-changing results with our BIOMAX customers, as they have been extremely patient in waiting for the availability of SARS -CoV-2 testing.
Having the data to prove the technology is effective against SARS-CoV-2 on both substrate types is a huge step-change for the industry and it will now allow the technology to be rolled out quickly across all markets. This shows that in the challenge of wall cladding vs coronavirus causing viruses, Saniclad is leading the way. Saniclad BioMax is now installed in major healthcare buildings across the world, including leading NHS hospitals.
*Results show the efficacy of Biomaster protected products only.